These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9381643)
41. Impaired apparent ion demand in experimental diabetic retinopathy: correction by lipoic Acid. Berkowitz BA; Roberts R; Stemmler A; Luan H; Gradianu M Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4753-8. PubMed ID: 17898301 [TBL] [Abstract][Full Text] [Related]
42. [Use of atromide-S in the treatment of diabetic retinopathy]. Kliachko VR; Tirkina TN; Aleksandrova LM; Mazovetskiĭ AG Sov Med; 1973 Dec; 36(12):59-61. PubMed ID: 4779364 [No Abstract] [Full Text] [Related]
43. [Manifestations of immunopathology and validation of immunotherapy of diabetic retinopathy]. Zaĭtseva NS; Dudnikova LK; Slepova OS; Li LS; Smirnova NB; Zueva MV; Kalamkarov GR; Shevchenko TF Vestn Oftalmol; 1997; 113(1):27-31. PubMed ID: 9133040 [TBL] [Abstract][Full Text] [Related]
44. [Clinical aspects and overall drug treatment of diabetic retinopathy]. Khriapchenkova MP; Boreĭko TG; Iasnetsova NM Oftalmol Zh; 1978; 33(1):41-5. PubMed ID: 345168 [No Abstract] [Full Text] [Related]
45. [Atromid and its analogs in the complex treatment of patients with diabetes mellitus and retinopathy]. Margolis MG; Zefirova GS; Tomenko LP; Shmushkovich VI Vestn Oftalmol; 1972; 2():70-2. PubMed ID: 4664149 [No Abstract] [Full Text] [Related]
46. [Various internal medicine aspects of the future therapy for diabetic retinopathy]. Houtsmuller AJ Klin Monbl Augenheilkd; 1972 May; 160(5):521-7. PubMed ID: 5075948 [No Abstract] [Full Text] [Related]
47. [Possibilities of appraisal of the evolutive stage of diabetic retinopathy]. Cofaru D; Păcurariu I; Vasinca M; Micluţia M Rev Chir Oncol Radiol O R L Oftalmol Stomatol Ser Oftalmol; 1979; 23(4):261-2. PubMed ID: 583510 [No Abstract] [Full Text] [Related]
48. Treatment of hypertension. Simpson LO N Z Med J; 1992 Mar; 105(929):90-1. PubMed ID: 1545952 [No Abstract] [Full Text] [Related]
49. Atromid-S in eye disease. Nolan J Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):563-6. PubMed ID: 4534191 [No Abstract] [Full Text] [Related]
50. [Use of Clofibrate SPOFA in the treatment of diabetic retinopathy]. Oláh Z Cesk Oftalmol; 1971 Sep; 27(5):315-8. PubMed ID: 5110678 [No Abstract] [Full Text] [Related]
51. [Using deltalicin for the treatment of patients with diabetic retinopathy]. Kresiun NV; Godlevskiĭ LS Eksp Klin Farmakol; 2014; 77(12):22-5. PubMed ID: 25739189 [TBL] [Abstract][Full Text] [Related]
52. [Anabolic steroid preparations in the complex therapy of diabetic retinopathy]. Margolis MG; Zefirova GS; Shul'pina NB Vestn Oftalmol; 1969; 82(4):64-6. PubMed ID: 5383941 [No Abstract] [Full Text] [Related]
53. [Observations on methylandrostanazole therapy of diabetic retinopathy]. Astrug A; Aladjov S Z Gesamte Inn Med; 1965 Dec; 20(23):Suppl:193-6. PubMed ID: 5333412 [No Abstract] [Full Text] [Related]
54. The role of lipid thrombi in the pathogenesis of diabetic retinopathy. Chester EM; Banker BQ Arch Intern Med; 1967 Oct; 120(4):397-407. PubMed ID: 6058095 [No Abstract] [Full Text] [Related]